The epidemiology of multiple sclerosis: Clues to the etiology of a mysterious disease

Neuroscientist

Volumn 2, Issue 3, 1996, Pages 172-180

  Cook, Stuart D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Canine distemper; Epidemiology; Etiology; Multiple sclerosis

Indexed keywords

EID: 0006239046     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200312     Document Type: Review

References (68)

1. The IFN-β Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Neurology 1993;43:655-661.
2. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993;6:382-427.
3. Kurtzke JF. MS epidemiology worldwide. One view of current status. Acta Neurol Scand Suppl 1995;161:23-33.
4. Kurtzke JF, Beebe GW, Norman JE. Epidemiology of multiple sclerosis in U.S. veterans: III. Migration and the risk of MS. Neurology 1985;35:672-678.
5. Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993;20:17-29.
6. Lauer K. Multiple sclerosis in the old world: the new old map (editorial). In: Firnhaber W, Lauer L, editors. Multiple sclerosis in Europe. An epidemiological update. Darmstadt: LTV Press 1994;14-27.
7. McLeod JG, Hammond SR, Hallpike JF. Epidemiology of multiple sclerosis in Australia with NSW and SA survey results. Med J Aust 1994;160:117-122.
8. Skegg DCG, Corwin PA, Craven RS, Malloch JA, Pollock M. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987;50:134-9.
9. Poskanzer DC, Prenney LB, Sheridan JL, Kondy JY. Multiple sclerosis in the Orkney and Shetland Islands. 1. Epidemiology, clinical factors and methodology. J Epidemiol Community Health 1980;34:229-39.
10. Kurtzke J, Hyllested K. MS in the Faroe Islands. I. Clinical and epidemiological features. Ann Neurol 1979;5:6-21.
11. Atkinson MA, MacLaren, NK. Mechanisms of disease: the pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994;331:1428-1436.
12. Poskanzer DC, Schapiro K, Miller H. Multiple sclerosis and poliomyelitis. Lancet 1963;2:917-21.
13. Nathanson W, Miller A. Epidemiology of multiple sclerosis, critique of the evidence for viral etiology. Am J Epidemiol 1978; 107:451-461.
14. Schwartz GG. Multiple sclerosis and prostate cancer: what do their similar geographies suggest? Neuroepidemiology 1992;11:244-254.
15. Lauer K. Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies. Acta Neurol Scand Suppl 1995;161:77-88.
16. Bulman DE, Ebers GC. The geography of MS reflects genetic susceptibility. J Trop Geogr Neurol 1992;2:66-72.
17. Hillert J. Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 1994;36:S15-S17.
18. Delasnerie-Laupretre N, Alperovitch A. Migration and age at onset of multiple sclerosis: some pitfalls of migrant studies. Acta Neurol Scand 1992;85:408-411.
19. Weinshenker BG. Epidemiologic strategies to detect an exogenous cause of MS. Acta Neurol Scand Suppl 1995;161:93-99.
20. Wolfson C, Wolfson DB. The latent period of multiple sclerosis: a critical review. Epidemiology 1993;4:464-470.
21. Hammond SR, English DR, Dewytte C, et al. The contribution of mortality statistics to the study of multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry 1989;52:1-7.
22. Dean G, Kurtzke JF. On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J 1980;3:725-729.
23. Alter M, Leibowitz U, Speer J. Risk of multiple sclerosis related to age at immigration to Israel. Arch Neurol 1970;15:234-237.
24. Elian M, Nightingale S, Dean G. MS among the United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 1990;50:327-332.
25. Kahana E, Zilber N, Abramson JH, Biton V, Leibowitz Y, Abramsky O. Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated. J Neurol 1994;241:341-346.
26. Detels R, Visscher B, Malmgren RM, Coulson A, Lucia M, Dudley J. Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans. Am J Epidemiol 1977;105:303-310.
27. Cook SD, Natelson BH, Levin BE, Chavis PS, Dowling PC. Further evidence of a possible association between house dogs and multiple sclerosis. Ann Neurol 1978;3:141-143.
28. Wynn DR, Rodriguez M, O'Fallon WM, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmstead County, Minnesota. Neurology 1990;40:780-786.
29. Larsen JP, Aarli JA, Riise T. Western Norway, a high risk area for multiple sclerosis. A prevalence/incidence study in the county of Hordaland. Neurology 1984;34:1202-1207.
30. Midgard R, Riise T, Kvale G, Nyland H. Disability and mortality in multiple sclerosis in Western Norway. Acta Neurol Scand. In press.
31. Koch-Henriksen N, Bronnum-Hansen H, Hyllested K. Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study. Neuroepidemiology 1992:11:1-10.
32. Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990;82:161-168.
33. Armon C, Daube JR, O'Brien PC, Kurland LT, Mulder DW. When is an apparent excess of neurologic cases epidemiologically significant? Neurology 1991:41:1713-1718.
34. Kurtzke J, Gudmundsson K, Bergmann S. MS in Iceland. 1. Evidence of a post-war epidemic. Neurology 1982;32:143-150.
35. Cook SD, Dowling PC, Norman J, Jablon S. Multiple sclerosis and canine distemper in Iceland. Lancet 1979;1:380-381.
36. Pryse-Phillips WEM. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador 1960-1984. Ann Neurol 1986;20:323-328.
37. Sheremata WA, Poskanzer DC, Withum DG, MacLeod CL, Whiteside ME. Unusual occurrence on a tropical island of multiple sclerosis. Lancet 1985;2:618.
38. Cook SD, Blumberg BM, Dowling PC. Potential role of paramyxoviruses in multiple sclerosis. In: Thornton G, Booss J, editors. Neurology clinics: infectious diseases of the nervous system. Philadelphia: Saunders 1986;303-319.
39. Sadovnick AD, Armstrong H, Rice GPA, et al. A population-based study of multiple sclerosis in twins: update. Ann Neurol 1993;33:281-285.
40. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988;29:533-541.
41. Doolittle TH, Myers RH, Lehrich JR, et al. Multiple sclerosis sibling pairs: clustered onset and familial predistribution. Neurology 1990;40:1546-1552.
42. Bulman DE, Sadovnick AD, Cripps J, Ebers GC. Age of onset in siblings concordant for multiple sclerosis. Brain 1991;114:937-950.
43. Compston DAS, Kellar WH, Robertson N, et. al. Genes and susceptibility to multiple sclerosis. Acta Neurol Scand Suppl 1995; 161:43-51.
44. Ebers GC. Genetics and multiple sclerosis: an overview. Ann Neurol 1994;36:S12-S14.
45. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 1995;161:34-42.
46. Eldridge R, Herndon CN. Multiple sclerosis in twins. N Engl J Med 1987;318:50.
47. Cook SD, Dowling PC. Multiple sclerosis and viruses: an overview. Neurology 1980;30:80-91.
48. Alter M, Cendrowski W. Multiple sclerosis and childhood infections. Neurology 1976;26:201-204.
49. Goverman J, Woods A, Larson L, et al. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993;72:551-560.
50. Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985;162:583-91.
51. Man, dogs, and hydatid disease. Lancet 1987;1:21-22.
52. Fuyinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985;230:1043-1045.
53. Johnson RT. The virology of demyelinating diseases. Ann Neurol 1994;36;554-560.
54. Vandevelde M, Higgins RJ, Kristensen B, Kristensen F, Steck A, Kihm U. Demyelination in experimental canine distemper virus infection: immunological, pathologic and immunohistological studies. Acta Neuropathol (Berl) 1982;56:285-293.
55. Yoshikawa Y, Ochikubo F, Matsubara Y, et al. Natural infection with canine distemper virus in a Japanese monkey. Vet Microbiol 1989;20:193-205.
56. Higgins RJ, Child G, Vandevelde M. Chronic relapsing demyelinating encephalomyelitis associated with persistent canine distemper virus infection. Acta Neuropathol (Berl) 1989;77:441-444.
57. Johnson GC, Fenner WR, Krakowka S. Production of immunoglobulin G and increased antiviral antibody in cerebrospinal fluid of dogs with delayed onset canine distemper viral encephalitis. J Neuroimmunol 1988;17:237-241.
58. Norman J, Cook SD, Dowling PC. Pilot survey of household pets among veterans with multiple sclerosis and age-matched controls. Arch Neurol 1983;40:213-214.
59. Cook SD, Blumberg BM, Dowling PC, Deans W, Cross R. Multiple sclerosis and canine distemper on Key West, Florida. Lancet 1987;1:1426-1427.
60. Cook SD, Dowling PC. Distemper and multiple sclerosis in Sitka, Alaska. Ann Neurol 1982;1:192-194.
61. Cook SD, Dowling PC, Russell WC. Multiple sclerosis and canine distemper. Lancet 1978;1:605-606.
62. Cook SD, Cromarty JI, Tapp W, et al. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985;35:545-551.
63. Benedikz J, Magnusson H, Poser C, et al. Multiple sclerosis in Iceland: 1900-1985. J Trop Geogr 1991;1:16-22.
64. Poser C, Hibberd P, Benedikz J, et al. An analysis of the "epidemic" of MS in the Faroe Islands. I. Clinical and epidemiological aspects. Neuroepidemiology 1988;7:168-180.
65. Kurtzke JF, Hyllested K, Arbuckle JD, et al. Multiple sclerosis in the Faroe Islands IV. The lack of a relationship between canine distemper and the epidemics of MS. Acta Neurol Scand 1988;78: 484-500.
66. Rohowsky-Kochan C, Dowling PC, Cook SD. Canine distemper specific antibodies in multiple sclerosis. Neurology. 1995;45: 1554-1560.
67. Crosby SL, McQuaid S, Taylor MJ, et al. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol 1989; 70:2027-2036.
68. Zurbriggen A, Müller C, Vandevelde M. In situ hybridization of virulent canine distemper virus in brain tissue, using digozigenin-labeled probes. Am J Vet Res 1993;54:1457-1461.